The gene signatures identified are promising tools for histo-pathological classification of non-small cell lung cancer, and may improve the prediction of clinical outcome.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: